XNAS: NKTR
Nektar Therapeutics Live Stock Price Today, Share Analysis and Chart
about
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company dir...
Read More
60.97
-5.87
(-8.78%)
3.3M
XNAS Volume
High volume+loss today
XNAS 22 Sep, 2026 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Nektar Therapeutics Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..